UCB

European Commission Approves Use of Anti-Epileptic Keppra(R) as Adjunctive Therapy in Children Four Years of Age and Older With Partial-Onset Seizures

Brussels, Belgium (ots/PRNewswire) - Today UCB announced that the European Commission has approved the use of Keppra(R) (levetiracetam) in the European Union, as adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalisation, in children from four to sixteen years of ...